Found: 47
Select item for more details and to access through your institution.
High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05208-9
- By:
- Publication type:
- Article
Review article: paradoxical psoriasis as a consequence of tumour necrosis factor antagonists in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 11, p. 1379, doi. 10.1111/apt.16883
- By:
- Publication type:
- Article
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1442, doi. 10.1111/apt.16626
- By:
- Publication type:
- Article
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 7, p. 784, doi. 10.1111/apt.16248
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.
- Published in:
- Pharmaceutical Research, 2017, v. 34, n. 8, p. 1556, doi. 10.1007/s11095-017-2150-2
- By:
- Publication type:
- Article
Emerging Therapies for Inflammatory Bowel Diseases.
- Published in:
- Digestive Diseases, 2016, v. 34, p. 67, doi. 10.1159/000447378
- By:
- Publication type:
- Article
Anti-Integrins in Ulcerative Colitis and Crohn's Disease: What Is Their Place?
- Published in:
- Digestive Diseases, 2016, v. 33, n. 1/2, p. 153, doi. 10.1159/000443132
- By:
- Publication type:
- Article
Targeting Leukocyte Trafficking in Inflammatory Bowel Disease: What Is the Clinical Evidence?
- Published in:
- Digestive Diseases, 2015, v. 33, p. 95, doi. 10.1159/000437103
- By:
- Publication type:
- Article
Challenging Question: Is Treating Inflammatory Bowel Disease an Art or Strictly an Evidence-Based Matter?
- Published in:
- Digestive Diseases, 2013, v. 31, n. 2, p. 213, doi. 10.1159/000353371
- By:
- Publication type:
- Article
Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 333, doi. 10.1007/s40265-020-01460-3
- By:
- Publication type:
- Article
Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
- Published in:
- Drugs, 2017, v. 77, n. 4, p. 379, doi. 10.1007/s40265-017-0719-z
- By:
- Publication type:
- Article
Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.
- Published in:
- Drugs, 2017, v. 77, n. 4, p. 363, doi. 10.1007/s40265-017-0693-5
- By:
- Publication type:
- Article
Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 6, p. 251, doi. 10.1093/jcag/gwac009
- By:
- Publication type:
- Article
Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 6, p. 271, doi. 10.1093/jcag/gwac020
- By:
- Publication type:
- Article
Cost-Effectiveness of Tight Control for Crohn's Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 4, p. 169, doi. 10.1093/jcag/gwac001
- By:
- Publication type:
- Article
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. S20, doi. 10.1093/jcag/gwab029
- By:
- Publication type:
- Article
Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. S10, doi. 10.1093/jcag/gwab028
- By:
- Publication type:
- Article
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. S1, doi. 10.1093/jcag/gwab027
- By:
- Publication type:
- Article
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2019, v. 2, n. 3, p. e1, doi. 10.1093/jcag/gwz019
- By:
- Publication type:
- Article
Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2018, v. 1, n. 4, p. 141, doi. 10.1093/jcag/gwy047
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel Disease.
- Published in:
- Gastroenterology & Hepatology, 2014, v. 10, n. 8, p. 478
- By:
- Publication type:
- Article
Adverse Metabolic Sequelae Following Restorative Proctocolectomy with an Ileal Pouch.
- Published in:
- Gastroenterology & Hepatology, 2012, v. 8, n. 5, p. 322
- By:
- Publication type:
- Article
Ustekinumab Therapeutic Drug Monitoring—Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 7, p. 3148, doi. 10.1007/s10620-021-07173-1
- By:
- Publication type:
- Article
A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 12, p. 4436, doi. 10.1007/s10620-020-06773-7
- By:
- Publication type:
- Article
Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Incidental Diagnosis of Ectopic Pregnancy with Unusual Clinical Presentation.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 1994, v. 34, n. 5, p. 579, doi. 10.1111/j.1479-828X.1994.tb01116.x
- By:
- Publication type:
- Article
Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada.
- Published in:
- Crohn's & Colitis 360, 2024, v. 6, n. 2, p. 1, doi. 10.1093/crocol/otae031
- By:
- Publication type:
- Article
Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis.
- Published in:
- Pharmacotherapy, 2015, v. 35, n. 4, p. 412, doi. 10.1002/phar.1561
- By:
- Publication type:
- Article
Environmental prevention of human disease from verocytotoxin-producing Escherichia coli.
- Published in:
- Nephrology Dialysis Transplantation, 2008, v. 23, n. 6, p. 1819, doi. 10.1093/ndt/gfn125
- By:
- Publication type:
- Article
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1047, doi. 10.1111/apt.15726
- By:
- Publication type:
- Article
Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population‐based cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 10, p. 1086, doi. 10.1111/apt.15511
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 1, p. 5, doi. 10.1111/apt.15297
- By:
- Publication type:
- Article
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 11, p. 1401, doi. 10.1111/apt.15250
- By:
- Publication type:
- Article
Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1188, doi. 10.1111/apt.15214
- By:
- Publication type:
- Article
Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1201, doi. 10.1093/ecco-jcc/jjz087
- By:
- Publication type:
- Article
Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 2, p. 167, doi. 10.1093/ecco-jcc/jjx130
- By:
- Publication type:
- Article
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 1, p. 105, doi. 10.1093/ecco-jcc/jjx117
- By:
- Publication type:
- Article
Evolving Concepts in Phases I and II Drug Development for Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 2, p. 246, doi. 10.1093/ecco-jcc/jjw137
- By:
- Publication type:
- Article
Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 9, p. 1006, doi. 10.1093/ecco-jcc/jjw120
- By:
- Publication type:
- Article
Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
- Published in:
- Journal of Crohn's & Colitis, 2016, v. 10, n. 5, p. 607, doi. 10.1093/ecco-jcc/jjw004
- By:
- Publication type:
- Article
Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 7, p. 994, doi. 10.1038/ajg.2014.110
- By:
- Publication type:
- Article
Continuing Medical Education Questions: June 2011.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 6, p. 1038, doi. 10.1038/ajg.2011.167
- By:
- Publication type:
- Article
Continuing Medical Education Questions: April 2011.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 4, p. 600, doi. 10.1038/ajg.2011.99
- By:
- Publication type:
- Article
Continuing Medical Education Questions: February 2011.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2011, v. 106, n. 2, p. 224, doi. 10.1038/ajg.2010.509
- By:
- Publication type:
- Article
Continuing Medical Education Questions: November 2010.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2010, v. 105, n. 11, p. 2437, doi. 10.1038/ajg.2010.420
- By:
- Publication type:
- Article